PLXP
NASDAQ:PLXP
PLx Pharma Inc.
- Stock
Last Close
0.09
12/04 20:00
Market Cap
2.53M
Beta: 3.92
Volume Today
50.38M
Avg: 4.86M
PE Ratio
−0.13
PFCF: −0.06
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -13.58M - | -18.74M 38.01% | -21.32M 13.76% | -15.35M 28.02% | 896.48K 105.84% | -20.50M 2,386.99% | -15.21M 25.81% | -46.13M 203.24% | |
depreciation and amortization | 29.84K - | 200.96K 573.49% | 158.25K 21.25% | 415.61K 162.63% | 213K 48.75% | ||||
deferred income tax | -920K - | 5.72M - | 1.66M 70.96% | 5.49M 230.56% | |||||
stock based compensation | 1.42M - | 3.28M 130.97% | 3.63M 10.85% | 1.62M 55.27% | 841.42K 48.20% | 875.85K 4.09% | 1.29M 47.11% | 2.88M 123.84% | |
change in working capital | 436.17K - | 319.69K 26.71% | 1.41M 341.98% | -2.70M 291.22% | 248.95K 109.21% | 871.20K 249.96% | -490.60K 156.31% | 5.41M 1,203.54% | |
accounts receivables | -14.31K - | 1.15K 108.04% | -449 139.04% | 18.68K 4,261.02% | -635K 3,498.81% | ||||
inventory | -449.38K - | -524.25K 16.66% | 328.41K 162.64% | -143.38K 143.66% | -2.31M 1,513.89% | ||||
accounts payables | 559.59M - | -2.24M - | -194.52K 91.31% | 448.87K 330.75% | -66.35K 114.78% | 9.74M 14,776.05% | |||
other working capital | -559.15M - | 319.69K 100.06% | 1.41M 341.98% | 1.32K 99.91% | 966.57K 73,069.27% | 94.38K 90.24% | -299.55K 417.40% | -1.38M 359.02% | |
other non cash items | 450.01K - | 554.59K 23.24% | 693.73K 25.09% | 4.01M 477.73% | -11.69M 391.61% | 215.29K 101.84% | 91.88K 57.32% | 3K 96.73% | |
net cash provided by operating activities | -11.28M - | -14.59M 29.41% | -15.58M 6.79% | -13.31M 14.61% | -9.50M 28.61% | -12.66M 33.26% | -12.24M 3.28% | -32.12M 162.32% | |
investments in property plant and equipment | -537.57K - | -654.87K 21.82% | -241.74K 63.09% | -102K 57.81% | |||||
acquisitions net | 12M - | ||||||||
purchases of investments | -30.96M - | -12.98M 58.08% | |||||||
sales maturities of investments | 40M - | ||||||||
other investing activites | 4M - | -223.57K - | 11.44K - | 95K - | |||||
net cash used for investing activites | -26.96M - | 27.02M 200.25% | 11.24M 58.41% | -654.87K 105.83% | -230.29K 64.83% | -102K 55.71% | 95K 193.14% | ||
debt repayment | -3.13M - | -3.75M 20% | -625K 83.33% | ||||||
common stock issued | 34.46M - | 19.74M 42.70% | 16.70M - | 2.10M - | 16.82M 699.49% | 74.48M 342.84% | |||
common stock repurchased | 13.75M - | 1.74M 87.37% | 8.04M 362.50% | ||||||
dividends paid | -13.75M - | -1.74M 87.37% | -8.04M 362.50% | ||||||
other financing activites | 9.71M - | 13.66M - | 7.72M 43.47% | 5.11M 33.88% | |||||
net cash used provided by financing activities | 34.46M - | 19.74M 42.70% | 26.41M - | 12.64M - | 20.79M 64.50% | 78.97M 279.77% | |||
effect of forex changes on cash | |||||||||
net change in cash | 23.18M - | -21.81M 194.07% | 11.44M 152.47% | 24.35M 112.80% | -10.15M 141.71% | -248.96K 97.55% | 8.45M 3,493.01% | 46.94M 455.71% | |
cash at beginning of period | 3.86M - | 27.04M 600.32% | 5.23M 80.64% | 59.34K 98.87% | 24.40M 41,029.80% | 14.25M 41.61% | 14.00M 1.75% | 22.45M 60.34% | |
cash at end of period | 27.04M - | 5.23M 80.64% | 16.68M 218.54% | 24.40M 46.35% | 14.25M 41.61% | 14.00M 1.75% | 22.45M 60.33% | 69.39M 209.11% | |
operating cash flow | -11.28M - | -14.59M 29.41% | -15.58M 6.79% | -13.31M 14.61% | -9.50M 28.61% | -12.66M 33.26% | -12.24M 3.28% | -32.12M 162.32% | |
capital expenditure | -537.57K - | -654.87K 21.82% | -241.74K 63.09% | -102K 57.81% | |||||
free cash flow | -11.28M - | -14.59M 29.41% | -15.58M 6.79% | -13.84M 11.16% | -10.15M 26.65% | -12.90M 27.05% | -12.35M 4.30% | -32.12M 160.16% |
All numbers in USD (except ratios and percentages)